The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.
"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.
'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'"
From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.
The Internet of Things (IoT) growth in broadband households opens up opportunities for companies to sell products and services. Companies developing, manufacturing, and marketing products benefit, and...
In a study published by research firm Parks Associates, it estimated that streaming services would lose $500 million in revenue from password-sharing in 2015, but Netflix still doesn’t seem so concern...
Roku continues to be the market leader for streaming devices, but Amazon’s Fire TV devices have made significant inroads over the last year, according to a report released by market research firm Park...
We compare two major analyses of 2016 digital health funding, note a tender opportunity and an award in UK, and two more chapters of the Theranos Story. The ActiveProtective CEO responds to Reader and...
